Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 5/20 | 0.58 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.57 |
| ▸ | ACE | P12821 | 6/20 | 0.56 |
| ▸ | CPA1 | P15085 | 1/20 | 0.56 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.56 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.55 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | YARS1 | P54577 | 2/20 | 0.51 |
| ▸ | NPY1R | P25929 | 1/20 | 0.51 |
| ▸ | NPY2R | P49146 | 1/20 | 0.51 |
| ▸ | NPY4R | P50391 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2228574 | 1.00 | MME (0.58) | MMESLC7A5ACECPA1ACE2 | |
| SCHEMBL30122989 | 0.96 | MME (0.54) | MMESLC7A5ACECPA1ACE2 | |
| SCHEMBL29630361 | 0.96 | MME (0.54) | MMESLC7A5ACECPA1ACE2 | |
| SCHEMBL30839491 | 0.95 | MME (0.53) | MMESLC7A5ACECPA1ACE2 | |
| SCHEMBL30123104 | 0.93 | ENPEP (0.56) | MMESLC7A5ACECPA1ACE2 | |
| SCHEMBL29619568 | 0.93 | ENPEP (0.56) | MMESLC7A5ACECPA1ACE2 | |
| SCHEMBL29430160 | 0.92 | ENPEP (0.55) | MMESLC7A5ACECPA1ACE2 | |
| SCHEMBL1574161 | 0.91 | SLC7A5 (0.65) | MMESLC7A5ACECPA1ACE2 | |
| SCHEMBL1574158 | 0.91 | SLC7A5 (0.65) | MMESLC7A5ACECPA1ACE2 | |
| SCHEMBL31025673 | 0.91 | SLC7A5 (0.65) | MMESLC7A5ACECPA1ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12050228-B2 | Automated sample quality assessment | METABOLON, INC. (US) | 2024-07-30 | — | — | US | claimed |
| US-11382911-B2 | Plant extract containing diketopiperazine and method for producing same | SUNTORY HOLDINGS LIMITED (JP) | 2022-07-12 | — | — | US | claimed |
| US-20210088539-A1 | AUTOMATED SAMPLE QUALITY ASSESSMENT | METABOLON, INC. | 2021-03-25 | — | — | US | claimed |
| US-10890592-B2 | Automated sample quality assessment | METABOLON, INC. (US) | 2021-01-12 | — | — | US | claimed |
| WO-2020071258-A1 | PROTEIN GLYCATION SUPPRESSANT | 味の素株式会社 | 2020-04-09 | — | — | WO | claimed |
| EP-3967217-B1 | BLOOD BASED BIOMARKERS FOR DIAGNOSING ATHEROSCLEROTIC CORONARY ARTERY DISEASE | GLOBAL GENOMICS GROUP LLC (US) | 2024-08-14 | — | — | EP | disclosed |
| US-20240257973-A1 | DISEASE SPECTRUM CLASSIFICATION | PATIENTSLIKEME LLC (US) | 2024-08-01 | — | — | US | disclosed |
| US-12050228-B2 | Automated sample quality assessment | METABOLON, INC. (US) | 2024-07-30 | — | — | US | disclosed |
| US-11894139-B1 | Disease spectrum classification | PATIENTSLIKEME LLC (US) | 2024-02-06 | — | — | US | disclosed |
| US-11421223-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. (US) | 2022-08-23 | — | — | US | disclosed |
| US-11382911-B2 | Plant extract containing diketopiperazine and method for producing same | SUNTORY HOLDINGS LIMITED (JP) | 2022-07-12 | — | — | US | disclosed |
| EP-3967217-A1 | BLOOD BASED BIOMARKERS FOR DIAGNOSING ATHEROSCLEROTIC CORONARY ARTERY DISEASE | Global Genomics Group, LLC (US) | 2022-03-16 | — | — | EP | disclosed |
| WO-2015017866-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. (US) | 2015-02-05 | — | — | WO | disclosed |
| EP-0109418-A4 | GONADOLIBERIN DERIVATIVES, PROCESS FOR THE PREPARATION AND PHARMACEUTICAL AND VETERINARY COMPOSITIONS THEREOF. | RICHTER GEDEON VEGYESZET (HU) | 1987-11-12 | — | — | EP | disclosed |
| US-4691008-A | COUPLING A URETHANE-BLOCKED TRIPEPTIDE AND A PEPTIDE WITH A FREE AMINE USING A CONDENSATION AGENT | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-09-01 | — | — | US | disclosed |
| US-4552864-A | Gonadoliberin derivatives process for the preparation and pharmaceutical compositions thereof | REANAL FINOMVEGYSZERGYAR (HU) | 1985-11-12 | — | — | US | disclosed |
| EP-0109418-A1 | GONADOLIBERIN DERIVATIVES, PROCESS FOR THE PREPARATION AND PHARMACEUTICAL AND VETERINARY COMPOSITIONS THEREOF | REANAL FINOMVEGYSZERGYAR (HU) | 1984-05-30 | — | — | EP | disclosed |
| WO-1983004250-A1 | GONADOLIBERIN DERIVATIVES, PROCESS FOR THE PREPARATION AND PHARMACEUTICAL AND VETERINARY COMPOSITIONS THEREOF | RICHTER GEDEON VEGYÉSZETI GYÁR R.T. (HU) | 1983-12-08 | — | — | WO | disclosed |
| US-4242256-A | Synthesis of peptide analogues | SHARPE ROBERT (GB) | 1980-12-30 | — | — | US | disclosed |
| US-3963691-A | POLYPEPTIDES, PEPTIZATION | MERCK & CO., INC. (US) | 1976-06-15 | — | — | US | disclosed |